Unknown Author
January 24, 2026
Kirkland Advises Gryphon Investors-Backed Vetnique Labs on Acquisition of Lintbells

1 min
AI-made summary
- Kirkland & Ellis is advising Vetnique Labs, which is backed by Gryphon Investors, on its acquisition of Lintbells, a company known for its YuMOVE brand of pet supplements
- YuMOVE is recognized as the UK's leading joint mobility supplement for dogs and cats and also offers products for digestive, anxiety, dermatological, and dental health
- The transaction is expected to close in the third quarter of 2024.
Kirkland & Ellis is advising Gryphon Investors-backed Vetnique Labs on its acquisition of Lintbells, a globally recognized leader in pet supplements sold under the YuMOVE brand. YuMOVE is the UK's number one joint mobility supplement for dogs and cats and offers supplements that support digestive health, anxiety, dermatological and dental needs. The transaction is expected to close in the third quarter of 2024. Read Vetnique Labs’ press release The Kirkland team is led by corporate partners Jacob Traff, Dana Abdulkarim, Benjamin Clinger and Kat Murphy and associates Yoana Georgieva, Talodabioluwa Olu-Odugbemi, Josh Jones and Jacob Reichman; debt finance partners James Dickson, Nisha Kanchanapoomi and Byron Nicol and associates Jay Kim, Nick Parker, Preston Loh and Annie Zhao; and tax partners Peter Abbott, David Morris and Sam Trowbridge.
Article Author
Unknown Author
The Sponsor
